… PSMA is an excellent target for radionuclide imaging and therapy of prostate cancer for
several reasons. PSMA is (1) mainly expressed in the prostate, (2) highly expressed at all stages …

… As shown in this study, metastatic tumors had much higher FN expression than the primary
tumor, enabling sufficient binding of the contrast agent in micrometastases for sensitive …

… HER-2 status in primary breast invasive carcinomas and in … -2 status on 119 cases of primary
infiltrating breast carcinoma and paired … was demonstrated between primary carcinoma and …

… like magnetic resonance imaging, near infrared imaging and … and others 17 to be the primary
epitope recognized by uPAR. … Thus, in this study, we utilized ATF to target tumors that over-…

… Nanoparticle-mediated photothermal therapy has been used widely as both a primary mode
… at weakening otherwise resistant cells toward treatment with conventional therapies 65, 66. …

… -based therapy. To ensure robust information during the development of nanomaterials for
PET/SPECT imaging and/or radionuclide therapy, … products for in vivo imaging and/or therapy. …

… and to inhibit the growth of primary and metastatic tumors following intravenous injection into
… that will express therapeutic agents and reporter transgenes for non-invasive imaging. We …

… ]) PET/CT could predict primary resistance to hormonal therapy in ER-positive breast cancer.
… , and had never received prior endocrine therapy were prospectively enrolled in this study. …

… therapy is that they have at least 1 dominant first-treated lesion, we hypothesized that this
lesion may be prospectively identified as the “primary … Investigators have shown that imaging …

… important potential implications of these barriers for imaging and imaging-guided therapy. …
agents for tumor imaging and therapy. The molecule must be delivered to the target tissue in …